1. Introduction {#s0005}
===============

*Arabidopsis thaliana* is the preferred organism for the investigation of the glycan structure--function relationship in plants. By analysis of mutants with defects in various maturation steps it has become clear that N-glycan processing is essential for plant development ([@b0015; @b0020; @b0035; @b0095]) and for abiotic as well as biotic stress reactions ([@b0055; @b0075; @b0100]). N-glycosylation mutants displaying a severe developmental defect have also drastically altered cell walls and many proteins involved in cell wall synthesis or remodelling are glycoproteins ([@b0075; @b0095; @b0210]). Moreover, plasma membrane located receptor kinases essential for plant growth (e.g. BRI1) or pathogen perception (e.g. EFR, FLS2) are heavily glycosylated and contain numerous N-glycosylation sites in their extracellular ligand binding domains ([@b0040; @b0090; @b0230]). In spite of these important findings, the analysis of the glycosylation site occupancy and oligosaccharide structures present on individual *A. thaliana* glycoproteins have been largely ignored in the past. The glycosylation status of endogenous *A. thaliana* proteins has mainly been determined by shifts in mobility on SDS--PAGE upon enzymatic or chemical deglycosylation and consequently the extent and heterogeneity of the attached oligosaccharide structures are unknown. Apart from the glycan analysis of recombinant proteins expressed in different *A. thaliana* organs (e.g. [@b0145; @b0190]) structural information of N-glycans is derived mainly from studies performed by enzymatic release of the oligosaccharides from total protein extracts ([@b0045; @b0070; @b0120; @b0125; @b0165]). The first comprehensive analysis of N-glycosylation sites present in the *A. thaliana* proteome has been reported recently ([@b0225]) and in one study glycopeptides from the putative cell wall proteome have been identified by MALDI-TOF MS ([@b0210]).

Here, we performed for the first time a detailed characterization of the N-glycan structures present on two endogenous glycoproteins isolated from *A. thaliana* leaves. The oligosaccharide structures present on the myrosinases THIOGLUCOSIDE GLUCOHYDROLASE1 (TGG1) and TGG2 were determined by mass spectrometry of glycopeptides and chromatographic comparison by porous graphitic carbon-liquid chromatography--electrospray ionization mass spectrometry (PGC-LC--ESI-MS). TGG1 and TGG2 belong to the glycoside hydrolase superfamily and produce toxic compounds against pathogens and insects by catalyzing the hydrolysis of glucosinolates ([@b0010; @b0050]). The two myrosinases display an organ-specific expression pattern and accumulate mainly in rosette leaves, flowers and siliques, but not in roots ([@b0185]). In previous studies it has been shown that TGG1 and TGG2 have redundant functions in terms of glucosinolate degradation and hormone signalling ([@b0010; @b0060]). Both enzymes are glycosylated, but the number of glycans, the type of glycans and the specific role of N-glycosylation for their biological function are unknown ([@b0185; @b0220]).

2. Results and discussion {#s0010}
=========================

2.1. TGG1 and TGG2 accumulate abnormally in mns mutants {#s0015}
-------------------------------------------------------

In a previous study we have identified *mns* mutants with defects in processing of oligomannosidic N-glycans ([@b0095]). The *mns* mutants display altered root formation and the triple mutant (*mns1 mns2 mns3*) which completely lacks class I α-mannosidase activity, exhibits reduced leaf growth and rosette diameter. To identify potential candidate glycoproteins whose functions are altered in *mns* mutants compared to wild-type plants, we analyzed total protein extracts from leaves by SDS--PAGE and Coomassie Brilliant Blue staining. Two aberrant bands of ca. 75 and 65 kDa were detectable in the mutants ([Fig. 1](#f0005){ref-type="fig"}A). The two protein bands were excised from the gel, tryptic digested and analyzed by ESI-MS. Peptides from the 75 kDa protein band could be assigned to TGG1 and peptides from the 65 kDa band to TGG2 (data not shown). Immunoblot analysis with antibodies specific for TGG1 and TGG2 confirmed that both the mobility and the abundance of the two myrosinases are altered in *mns* mutants compared to control plants ([Fig. 1](#f0005){ref-type="fig"}B and C). In particular, the *mns1 mns2 mns3* triple mutant displayed a pronounced shift and an almost 3-fold increase in signal intensity for TGG1 and TGG2. Differences in abundance of TGG1 have also been described for mutants with defects in the assembly of N-glycans ([@b0030; @b0080; @b0200; @b0205]) suggesting that N-glycosylation of myrosinases could affect their stability.

2.2. TGG1 and TGG2 are glycosylated with oligomannosidic N-glycans {#s0020}
------------------------------------------------------------------

To assess the degree of N-glycan processing protein extracts from *A. thaliana* wild-type leaves were subjected to endoglycosidase H (Endo H) and Peptide: N-glycosidase F (PNGase F) digestion followed by immunoblotting with TGG1 and TGG2 specific antibodies. For both myrosinases shifts in mobility were visible upon enzymatic deglycosylation and the Endo H and PNGase F digested bands showed co-migration, which is indicative for the presence of predominantly oligomannosidic N-glycans ([Fig. 2](#f0010){ref-type="fig"}A and B). However, plant complex N-glycans frequently contain α1,3-fucose residues linked to the innermost GlcNAc, which make them insensitive to PNGase F digestion ([@b0180]). Therefore we performed endoglycosidase treatments of TGG1 and TGG2 in the *fut11 fut12* line, which generates complex N-glycans lacking core α1,3-fucose ([@b0165]). Deglycosylated TGG1 and TGG2 from *fut11 fut12* were indistinguishable from deglycosylated wild-type forms strongly indicating the absence of any α1,3-fucosylated complex N-glycans ([Fig. 2](#f0010){ref-type="fig"}C and D).

Next we investigated the glycan site occupancy and glycan structures of TGG1 and TGG2. Protein extracts from *A. thaliana* leaves were separated by SDS--PAGE, bands corresponding to TGG1 and TGG2 were excised from the gel, digested by proteases and analyzed by mass spectrometry. For TGG1 nine glycopeptides were identified showing that all potential N-glycosylation sites are subjected to glycosylation ([Figs. 3](#f0015){ref-type="fig"} and [S1](#s0085){ref-type="sec"}). The TGG1 glycopeptides displayed masses matching with different oligomannosidic structures, but lack paucimannosidic or complex N-glycans. Man~5~GlcNAc~2~ was the main oligosaccharide found on the majority of TGG1 glycopeptides. In addition, Man~6~GlcNAc~2~, Man~7~GlcNAc~2~ and Man~8~GlcNAc~2~ were also present on several glycosylation sites while on Asn108 the predominant peak corresponds to Man~9~GlcNAc~2~ indicating that this glycopeptide is not accessible for further N-glycan trimming. The same N-glycan structures were observed when TGG1 was purified by Concanavalin A Sepharose from protein extracts followed by LC--ESI-MS analysis (data not shown).

For TGG2, four glycopeptides could be identified revealing that TGG2 is fully glycosylated. The assigned glycan profile of TGG2 is very similar to TGG1 showing only oligomannosidic N-glycans with Man~5~GlcNAc~2~ as predominant peak ([Fig. S2](#s0085){ref-type="sec"}).

2.3. TGG1 from mns mutants display incompletely processed oligomannosidic N-glycans {#s0025}
-----------------------------------------------------------------------------------

The observed shifts in mobility on protein gels suggest that both myrosinases are aberrantly glycosylated in the mannose trimming deficient *mns* mutants. Consequently, we analyzed corresponding glycopeptides of TGG1 from different *mns* mutants to figure out if the myrosinase is indeed processed by MNS proteins. Consistent with the previously described glycosylation defect ([@b0095]) TGG1 N-glycans from *mns3* plants displayed increased levels of Man~6~GlcNAc~2~ and Man~7~GlcNAc~2~ structures. The spectra derived from *mns1 mns2* double and *mns1 mns2 mns3* triple knockouts contained almost exclusively Man~8~GlcNAc~2~ and Man~9~GlcNAc~2~ N-glycans, respectively ([Figs. 4](#f0020){ref-type="fig"} and [S3](#s0085){ref-type="sec"}). These data show clearly that TGG1 N-glycans are processed by MNS3 and MNS1/MNS2.

Since oligomannosidic N-glycans very often represent a mixture of different isomers we subjected released N-glycans from TGG1 to PGC-LC--ESI-MS analysis, which allows the separation and identification of oligomannosidic isomers ([@b0115]). PGC-LC analysis confirmed the presence of Man~5~GlcNAc~2~ to Man~9~GlcNAc~2~ oligosaccharide structures. The Man~5~GlcNAc~2~ isomer (M^6^M^3^)M was the most abundant glycan on TGG1 extracted from wild-type plants ([Fig. 5](#f0025){ref-type="fig"}). Accordingly, we could assign the predominant Man~6~GlcNAc~2~ structure to (M^6^M^2-3^)M in *mns3* as well as the Man~8~GlcNAc~2~ to (M^2-6^M^3^)M^2-2^ in *mns1 mns2* and the Man~9~GlcNAc~2~ to (M^2-6^M^2-3^)M^2-2^ in *mns1 mns2 mns3* ([Table 1](#t0005){ref-type="table"}). These findings are in good agreement with current models of N-glycan processing in the early secretory pathway of *A. thaliana* ([@b0095]).

2.4. TGG1 transcript levels are higher in leaves of mns1 mns2 mns3 plants {#s0030}
-------------------------------------------------------------------------

The most prominent difference in expression levels were found for TGG1 in the *mns1 mns2 mns3* triple mutant ([Fig. 1](#f0005){ref-type="fig"}). It has been proposed that TGG1 is cell type-specific expressed in specialized myrosin cells and is also highly abundant in guard cells of leaves ([@b0050; @b0185; @b0215]). To monitor if the elevated TGG1 levels are caused by an increased number of guard cells we compared the stomata in leaves from *mns1 mns2 mns3* to wild-type plants ([Fig. 6](#f0030){ref-type="fig"}A). Neither the number nor the morphology of stomata was affected in the mutant.

Next we addressed whether TGG1 transcript expression is altered in the triple mutant. Quantitative PCR showed that TGG1 transcript levels are at least 5-fold higher in the *mns1 mns2 mns3* mutant ([Fig. 6](#f0030){ref-type="fig"}B) suggesting that under conditions of aberrant glycosylation increased amounts of TGG1 are beneficial for the plant. To investigate the effect of TGG1 deficiency in the *mns1 mns2 mns3* line, we generated *tgg1 mns1 mns2 mns3* quadruple knockouts and compared its growth and development to *mns1 mns2 mns3*. Under our growth conditions seedlings as well as the areal parts of soil grown quadruple knockouts were indistinguishable from *mns1 mns2 mns3* ([Fig. 6](#f0030){ref-type="fig"}C and D) being consistent with the current model that TGG1 is involved in glucosinolate breakdown to deter herbivores and pathogens but plays no role for the normal development of *A. thaliana* ([@b0010; @b0050; @b0185]).

2.5. TGG1 and TGG2 N-glycans are not altered in the mvp1 mutant {#s0035}
---------------------------------------------------------------

Recently, a protein trafficking mutant was identified, which displayed mislocalization of TGG1 and TGG2 to aggregates within the cell ([@b0005]). Apart from mistargeting of vacuolar proteins the *modified vacuole phenotype1* (*mvp1-1* and *mvp1-2*) mutants displayed also aberrant localization of Golgi-resident proteins as observed for a fluorescent protein tagged N-acetylglucosaminyltransferase I (GnTI or NAG1), which was used as a Golgi marker ([@b0005]). Since GnTI is the key enzyme for the initiation of complex N-glycan formation in plants ([@b0175; @b0195]) its aggregate formation in the *mvp1* mutants might cause aberrant glycosylation of proteins and could also affect the two myrosinases. To address whether *mvp1* plants display overall changes in N-glycan processing we first analyzed the total N-glycosylation profile of endogenous proteins. Despite the reported global defects in subcellular localization of proteins, the N-glycan profile from *mvp1-2* was essentially the same when compared with wild-type derived N-glycans ([Fig. S4](#s0085){ref-type="sec"}). In addition, aggregate formation of TGG1 and TGG2 in *mvp1-2* did not have an effect on their N-glycosylation profile. As shown in [Fig. S5](#s0085){ref-type="sec"} the processed oligomannosidic N-glycans on TGG1 and TGG2 glycopeptides resemble the oligosaccharides found on in wild-type derived myrosinases showing that neither the aberrant localization of the TGG1 and TGG2 nor global defects in protein trafficking result in changes of N-glycosylation in MVP1 deficient plants.

3. Conclusions {#s0040}
==============

The fundamental role of N-glycosylation for development and response to adverse environmental conditions is very well documented in the plant model organism *A. thaliana*. Remarkably, very little is known about the N-glycosylation of individual *A. thaliana* proteins and the specific function of their N-glycans. Here, we analyzed the glycans of two myrosinases expressed in leaves of wild-type plants and in four different mutant backgrounds. To date, this is the first comprehensive N-glycan analysis of endogenous *A. thaliana* glycoproteins with multiple N-glycosylation sites. Our structural analysis reveal that both myrosinases contain exclusively oligomannosidic N-glycans with the (M^6^M^3^)M Man~5~GlcNAc~2~ isomer as predominant structure. The data from the *mns* mutants confirm that this oligomannosidic N-glycan is processed by the α-mannosidases MNS1 to MNS3. Surprisingly, there is no further processing of TGG1 and TGG2 N-glycans by GnTI, which utilizes (M^6^M^3^)M as substrate to initiate hybrid and complex N-glycan formation in plants ([@b0175; @b0195]). MNS1 and MNS2 are like GnTI *cis*/medial Golgi-located enzymes ([@b0095; @b0065; @b0105; @b0130; @b0140; @b0160]) which raises the question how this myrosinase-specific glycosylation pattern is generated. We can provide three possible explanations: (i) the N-glycans from TGG1 and TGG2 are not accessible for GnTI and are therefore not further processed. There are no clear data from secreted plant glycoproteins available that support this explanation, but in mammals it has been shown that the occurrence of oligomannosidic N-glycans on the envelope glycoprotein from HIV-1 is at least in part caused by steric constraints that prevent further processing in the Golgi ([@b0025]). (ii) TGG1 and TGG2 are only expressed in specialized cells that lack GnTI activity. While this possibility cannot be ruled out it is commonly believed that most of the Golgi-located N-glycan processing enzymes are expressed ubiquitously in plants and with the exception of the Lewis a structures ([@b0170]) no cell- or organ-specific glycosylation profile has been described for *A. thaliana* so far. (iii) In TGG1 and TGG2 expressing cells MNS proteins and GnTI are located in different sub-Golgi compartments. If the final destination for both myrosinases is the vacuole ([@b0185]), this latter hypothesis would suggest a specific sorting from the *cis*-Golgi (or MNS compartment) to the vacuole without trafficking through other Golgi cisternae. Current models for subcellular localization of glycosylation enzymes suggest the existence of some kind of assembly line across the Golgi stack ([@b0130; @b0135]). However, additional studies using advanced imaging and protein--protein interaction technologies ([@b0150]) are required to reveal the organization of Golgi-located glycosylation enzymes in plants.

The biological significance of TGG1 and TGG2 N-glycosylation remains elusive and the mechanisms as well as the consequences of the increased myrosinase expression in the *mns1 mns2 mns3* mutant are unclear. Further studies are necessary to unravel a biological role for the processed oligomannosidic N-glycan structures on TGG1 and TGG2 and provide a link to myrosinase function during pathogen attack. In summary, our in depth structural analysis offers interesting new insights into N-glycan processing of individual plant proteins that are missed by mass spectrometry of N-glycans from large pools of glycoproteins.

4. Experimental {#s0045}
===============

4.1. Plant material and growth conditions {#s0050}
-----------------------------------------

*A. thaliana* wild-type (ecotype Columbia-0) and mutant plants were grown as described previously ([@b0095]). Seeds of *tgg1-1* ([@b0010]) and *mvp1-2* ([@b0005]) were obtained from the Nottingham Arabidopsis Stock Centre (NASC). Line *tgg1-1* was crossed with the *mns1 mns2 mns3* triple knockout line ([@b0095]) to generate the *tgg1 mns1 mns2 mns3* quadruple mutant. Homozygous lines were confirmed by genotyping using the following primer combinations: At1g51590-1F/2R for *mns1*, At3g21160-1F/2R for *mns2*, At1g30000-3F/2R for *mns3*; At5g26000-1F/2R for *tgg1* and MVP-1F/2R for *mvp1-2*. All primer sequences are presented in Table S1.

4.2. SDS--PAGE and LC--ESI-MS analysis of glycopeptides {#s0055}
-------------------------------------------------------

Rosette leaf material from *A. thaliana* wild-type and *mns* single, double and triple knockouts was ground in liquid nitrogen and resuspended in 1× phosphate buffered saline (PBS). Samples were incubated for 10 min on ice and then centrifuged for 10 min at 9.600*g*. The supernatant was centrifuged for 5 min at 9.600*g* and mixed with SDS--PAGE loading buffer. The samples were incubated for 5 min at 95 °C, separated by SDS--PAGE (10%) under reducing conditions and polypeptides were detected by Coomassie Brilliant Blue staining. The corresponding bands were excised from the gel, destained, carbamidomethylated, in-gel digested with trypsin and GluC and analyzed by LC--ESI-MS as described previously ([@b0155; @b0085]).

4.3. PGC-LC--ESI-MS analysis {#s0060}
----------------------------

For isomeric analysis, the above described glycopeptides were digested with peptide: N-glycosidase A (Proglycan, Vienna, Austria). The liberated glycans were reduced with sodium borohydride and subsequently purified using graphitic carbon cartridges ([@b0115]).

Reduced oligosaccharides were analyzed by PGC-LC--ESI-MS on a Hypercarb column (0.32 × 100 mm, Thermo Fisher Scientific) coupled to an Ultimate 3000 capillary HPLC (Thermo Fisher Scientific) and a Q-TOF Ultima MS (Waters) ([@b0110]) Briefly, the aqueous solvent was 0.3% formic acid buffered to pH 3.0 and a linear gradient from 8.8% to 17.2% acetonitrile was developed during 55 min. Detection was accomplished by positive mode ESI-MS. Assignment of isomers was based on reference oligosaccharides prepared from kidney beans and bovine ribonuclease B as described in detail previously ([@b0115]). For retention time normalization, the diantennary, complex-type asialo-N-glycan A^4^A^4^ was added to each sample.

4.4. Deglycosylation with PNGase F and Endo H {#s0065}
---------------------------------------------

Protein extraction from wild-type and *fuct11 fuct12* line ([@b0165]) was performed as described above. Prior to PNGase F/Endo H treatment, the protein extracts were mixed with 10x denaturation buffer (New England Biolabs, Frankfurt, Germany), boiled for 10 min at 98 °C and then cooled for 2 min on ice. For PNGase F digestion, the extract (10 μL) was mixed with 10× G7 reaction buffer containing 10% NP-40 (New England Biolabs), water and 0.5 U PNGase F (New England Biolabs) in a total volume of 15 μL. For Endo H digestion, the extract was mixed with 10× G5 reaction buffer (New England Biolabs), water and 0.5 U Endo H (New England Biolabs) in a total volume of 15 μL. Controls were treated as described above but the respective enzymes were replaced by water. After incubation of the reaction mixture for 3 h at 37 °C, SDS--PAGE loading buffer was added and the samples were heated to 95 °C for 5 min. Deglycosylated proteins and controls were subjected to SDS--PAGE (10%) followed by immunoblotting with anti-TGG1 and anti-TGG2 antibodies (kind gift of Ikuko Hara-Nishimura) ([@b0185]). A rabbit polyclonal antiserum against UDP-glucose pyrophosphorylase (anti-UGPase, Agrisera, Vännäs, Sweden) was used as a control for equal loading.

4.5. FM4-staining and imaging {#s0070}
-----------------------------

*A. thaliana* seedlings (6 to 8-day-old) were incubated in 50 μM FM4-64 dye (Invitrogen, F34653) for an appropriate time. Seedlings were then mounted on a slide and imaging of stomata was performed using a Leica TCS SP2 confocal laser scanning microscope as described previously ([@b0140]).

4.6. RNA Isolation, reverse transcription and qPCR {#s0075}
--------------------------------------------------

Total RNA from rosette leaves was isolated using a SV Total RNA Isolation kit (Promega). First strand cDNA was synthesized from 1.5 μg of total RNA at 42 °C using oligo dT primers and AMV reverse transcriptase (Promega) in a total volume of 20 μl. PCR reactions were performed in a Rotor-Gene RG-3000A (Corbett, Qiagen, Hilden, Germany). Reactions contained 4 μL 5× HOT FIREPol® EvaGreen® qPCR Mix Plus (no ROX) (Solis BioDyne, Tartu, Estonia), 0.1 μL cDNA and 300 nM of each gene-specific primer in a total volume of 20 μL. The following profile was used for all PCR reactions: 95 °C for 15 min, 40 cycles of 95 °C for 15 s, 60 °C for 20 s, 72 °C for 20 s. To detect TGG1 transcripts cDNA was amplified with primers At5g26000-11F/12R and normalized to the expression of the protein phosphatase 2A (PP2A) gene (primers At1g13320-1F/2R). The specificity of the PCR amplification was checked with a melting curve analysis from 65 to 99 °C and data were analyzed using Rotor-Gene software (version 6). PCR reactions were done in triplets and at least three independent biological experiments were performed.

Appendix A. Supplementary data {#s0085}
==============================

Supplementary data 1This document contains Supplementary Figs. S1--S5 and Table S1.
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![TGG1 and TGG2 abundance and mobility are altered in *mns* mutants. (A) Coomassie Brilliant Blue staining of protein extracts from wild-type, *mns3* single (3), *mns1 mns2* double (12) and *mns1 mns2 mns3* triple (123) mutants. (B) Immunoblot analysis using anti-TGG1 and (C) anti-TGG2 antibodies. Antibodies against UGPase were used as a control.](gr1){#f0005}

![TGG1 and TGG2 are sensitive to endoglycosidase digestion. Protein extracts of wild-type (A and B) and *fut11 fut12* (C and D) were digested with Endo H and PNGase F, subjected to SDS--PAGE and analyzed by immunoblotting with TGG1 (A and C) and TGG2 (B and D) specific antibodies.](gr2){#f0010}

![TGG1 glycopeptides contain exclusively oligomannosidic N-glycans. The spectra of all nine glycopeptides (GP 1-GP 9) derived from endogenous *A. thaliana* TGG1 are shown. Peaks corresponding to N-glycan structures are labelled. Sodium adducts are indicated (\#). Spectra were obtained by LC--ESI-MS analysis of trypsin/GluC double digests.](gr3){#f0015}

![TGG1 N-glycans are trimmed by class I α-mannosidases. LC--ESI-MS analysis of TGG1 glycopeptide 1 (GP 1) from wild-type, *mns3*, *mns1 mns2* and *mns1 mns2 mns3* mutants. Sodium adducts are indicated (\#).](gr4){#f0020}

![Determination of the predominant N-glycan isomers on TGG1. Selected ion chromatograms (SIC) of oligomannosidic N-glycans from TGG1 are shown. TGG1 was extracted from leaves of wild-type plants and reduced N-glycans were separated by PGC-LC--ESI-MS. The assignment of structural isomers was based on reference glycans as described in detail previously ([@b0115]).](gr5){#f0025}

![Phenotypic analysis of wild-type and mutant plants. (A) Images of the epidermis of mature rosette leaves. Lower panel: staining of stomata from Col-0 and *mns1 mns2 mns3* (*mns123*) with FM4-64 dye. Bar = 50 μm. (B) Quantitative real time PCR (qPCR) analysis of TGG1 transcript levels in wild-type and mutant plants. (C) Phenotypes of 3-week-old wild type and mutant plants grown on soil under long day conditions. (D) 10-day-old seedlings grown on 1× Murashige and Skoog medium supplemented with 2% sucrose. Bar = 5 mm.](gr6){#f0030}

###### 

N-Glycan isomers of TGG1.

  N-Glycan structure   Proglycan code       Relative abundance on individual glycosylation sites (%)                        
  -------------------- -------------------- ---------------------------------------------------------- ------ ------ ------ ------
  Man5                 Man5.1               (M^6^M^3^)M                                                56.8   15.8   --     --
                                                                                                                            
  Man6                 Man6.1               (M^6^M^3^)M^2^                                             15.3   --     --     --
  Man6.10              (M^6^M^2-3^)M        --                                                         51.5   --     --     
                                                                                                                            
  Man7                 Man7.1               (M^6^M^3^)M^2-2^                                           7.1    --     9.5    --
  Man7.2               (M^2-6^M^3^)M^2^     3.8                                                        --     20.8   --     
  Man7.7               (M^6^M^2-3^)M^2^     --                                                         10.5   --     --     
                                                                                                                            
  Man8                 Man8.1/8.4           (M^2-6^M^3^)M^2-2^/(M^2-6^M^2-3^)M^2^                      8.7    9.7    57.6   22.8
  Man8.2               (M^6^M^2-3^)M^2-2^   --                                                         2.0    --     3.1    
                                                                                                                            
  Man9                 Man9.1               (M^2-6^M^2-3^)M^2-2^                                       8.3    10.5   12.1   74.1

The Proglycan code for oligomannosidic glycans has been described in detail recently ([@b0115]).
